Bpifrance SA - Q2 2021 holdings

$4.5 Billion is the total value of Bpifrance SA's 8 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 14.3% .

 Value Shares↓ Weighting
STLA  STELLANTIS NV$3,787,814,000
+11.2%
192,703,9070.0%84.11%
-2.2%
CSTM  CONSTELLIUM NVcl a$310,664,000
+28.9%
16,393,9030.0%6.90%
+13.4%
FTI  TECHNIPFMC PLC$221,928,000
+17.7%
24,688,6910.0%4.93%
+3.5%
CRTO  CRITEO S Aspons ads$122,969,000
+30.2%
2,718,7520.0%2.73%
+14.6%
VECT NewVECTIVBIO HOLDING AG$32,720,0002,806,217
+100.0%
0.73%
SQNS  SEQUANS COMMUNICATIONS S Aspons ads$19,866,000
-0.3%
3,300,0180.0%0.44%
-12.3%
CLLS  CELLECTISspons ads$6,586,000
-23.5%
425,7260.0%0.15%
-32.7%
CRSP SellCRISPR THERAPEUTICS AG$777,000
-20.3%
4,800
-40.0%
0.02%
-32.0%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2021-07-30
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CRITEO S A20Q3 202310.1%
TECHNIPFMC PLC13Q4 202168.1%
STELLANTIS NV11Q3 202390.9%
CONSTELLIUM NV11Q2 202141.6%
SEQUANS COMMUNICATIONS S A11Q2 20215.8%
CELLECTIS S.A.10Q2 20232.3%
CONSTELLIUM NV9Q3 20238.3%
SEQUANSCOMMUNICATIONS S A9Q3 20230.5%
MILLENDO THERAPEUTICS INC8Q3 20201.8%
VECTIVBIO HOLDING AG8Q1 20230.8%

View Bpifrance SA's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-07
13F-HR2023-11-13
13F-HR2023-07-28
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-11
13F-HR2022-05-16
13F-HR2022-02-11
13F-HR2021-11-15

View Bpifrance SA's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export Bpifrance SA's holdings